Cerity Partners’s MaxCyte MXCT Stock Holding History

Cerity Partners’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Buy	97,858 +52,196	+114%	+$52K	﹤0.01%	3181
2026 Q1	$32.1K	Buy	+45,662	New	+$42.6K	﹤0.01%	3147
2025 Q4	–	Sell	-30,672	Closed	-$48.5K	–	2973
2025 Q3	$48.5K	Buy	+30,672	New	+$53.3K	﹤0.01%	2700
2023 Q3	–	Sell	-12,510	Closed	-$57.7K	–	1605
2023 Q2	$57.7K	Buy	+12,510	New	+$57.5K	﹤0.01%	1566

Other funds holding MXCT

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $128M AUM

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Cerity Partners's MXCT Position: Q2 2026 in Review

Cerity Partners increased its MaxCyte (MXCT) stake by 114% in Q2 2026, buying an estimated $52K and bringing the position to 97,858 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #3181.

Cerity Partners first reported a position in MXCT in Q2 2023 and has held it in 4 quarters since. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

Cerity Partners held 97,858 shares of MaxCyte worth $120K as of Q2 2026.
Cerity Partners bought 52,196 MaxCyte shares in Q2 2026, an estimated $52K.
MaxCyte made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3181 holding.
Cerity Partners first reported a position in MaxCyte in Q2 2023 and has held it in 4 quarters since.
122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.